Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis.

[1]  T. Sharp,et al.  Changes in monoamine metabolites measured by simultaneousin vivo differential pulse voltammetry and intracerebral dialysis , 1984, Neuroscience.

[2]  U. Ungerstedt,et al.  Effects of apomorphine on the in vivo release of dopamine and its metabolites, studied by brain dialysis. , 1984, European journal of pharmacology.

[3]  U. Ungerstedt,et al.  In Vivo Measurement of Dopamine and Its Metabolites by Intracerebral Dialysis: Changes After d‐Amphetamine , 1983, Journal of neurochemistry.

[4]  B. Westerink,et al.  On the Significance of Endogenous 3‐Methoxytyramine for the Effects of Centrally Acting Drugs on Dopamine Release in the Rat Brain , 1982, Journal of neurochemistry.

[5]  K. E. Moore,et al.  Measurement of metabolites of dopamine and 5-hydroxytryptamine in cerebroventricular perfusates of unanesthetized, freely-moving rats: Selective effects of drugs , 1982, Pharmacology Biochemistry and Behavior.

[6]  S. Z. Langer,et al.  Stereoselectivity of presynaptic autoreceptors modulating dopamine release. , 1981, European journal of pharmacology.

[7]  C. Perego,et al.  Differential effects of certain dopaminergic drugs on the striatal concentration of dopamine metabolites, with special reference to 3-methoxytyramine , 1981, Neuroscience Letters.

[8]  F. Gonon,et al.  Voltammetry in the striatum of chronic freely moving rats: Detection of catechols and ascorbic acid , 1981, Brain Research.

[9]  P. Seeman Brain dopamine receptors. , 1980, Pharmacological reviews.

[10]  N. Nicolaou Acute and chronic effects of neuroleptics and acute effects of apomorphine and amphetamine on dopamine turnover in corpus striatum and substantia nigra of the rat brain. , 1980, European journal of pharmacology.

[11]  J. Glowinski,et al.  Effects of the unilateral nigral application of dopaminergic drugs on the in vivo release of dopamine in the two caudate nuclei of the cat. , 1979, European journal of pharmacology.

[12]  R. Roth,et al.  Dopaminergic neurons: Role of presynaptic receptors in the regulation of transmitter biosynthesis , 1978 .

[13]  G. Chiara,et al.  Postsynaptic receptors are not essential for dopaminergic feedback regulation , 1977, Nature.

[14]  M. Garcia-Munoz,et al.  Feedback loop or output pathway in striato-nigral fibres? , 1977, Nature.

[15]  J. Korf,et al.  Comparison of effects of drugs on dopamine metabolism in the substantia nigra and the corpus striatum of rat brain. , 1976, European journal of pharmacology.

[16]  H. Stadler,et al.  The use of the push-pull cannula to estimate the dynamics of acetylcholine and catecholamines within various brain areas , 1976, Neuropharmacology.

[17]  S H Snyder,et al.  Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs , 1976, Science.

[18]  U. Ungerstedt,et al.  Functional correlates of dopamine neurotransmission. , 1974, Bulletin der Schweizerischen Akademie der Medizinischen Wissenschaften.

[19]  R. Roth,et al.  Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. , 1973, The Journal of pharmacology and experimental therapeutics.

[20]  N. Andén Dopamine turnover in the corpus striatum and the limbic system after treatment with neuroleptic and anti‐acetylcholine drugs , 1972, The Journal of pharmacy and pharmacology.

[21]  B. Hamberger,et al.  Drug-Induced Changes in the Release of 3H-Monoamines from Field Stimulated Rat Brain Slices , 1971 .

[22]  A. Carlsson,et al.  EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN. , 2009, Acta pharmacologica et toxicologica.